Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Urol. 2011 Jun;59(6):978-84. doi: 10.1016/j.eururo.2011.01.014. Epub 2011 Jan 18.

Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

Author information

1
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Abstract

CONTEXT:

The optimal treatment strategy for muscle-invasive bladder cancer remains controversial.

OBJECTIVE:

To determine optimal combination of chemotherapy and surgery aimed at preserving survival of patients with locally advanced bladder cancer.

EVIDENCE ACQUISITION:

We performed a critical review of the published abstract and presentation literature on combined modality therapy for muscle-invasive bladder cancer. We emphasized articles of the highest scientific level, combining radical cystectomy and perioperative chemotherapy with curative intent to affect overall and disease-specific survival.

EVIDENCE SYNTHESIS:

Locally invasive, regional, and occult micrometastases at the time of radical cystectomy lead to both distant and local failure, causing bladder cancer deaths. Neoadjuvant and adjuvant chemotherapy regimens have been evaluated, as well as the quality of cystectomy and pelvic lymph node dissection.

CONCLUSIONS:

Prospective, randomized clinical trials argue strongly for neoadjuvant cisplatin-based chemotherapy followed by high-quality cystectomy performed by an experienced surgeon operating in a high-volume center. Adjuvant chemotherapy after surgery is also effective when therapeutic doses can be given in a timely fashion. Both contribute to improved overall survival; however, many patients receive only one or none of these options, and the barriers to receiving optimal, combined, systemic therapy and surgery remain to be defined. An aging, comorbid, and often unfit population increasingly affected by bladder cancer poses significant challenges in management of individual patients.

PMID:
21257257
PMCID:
PMC3137649
DOI:
10.1016/j.eururo.2011.01.014
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center